Atlas Trials

Safety Study of Human Neural Stem Cells Injections for Secondary Progressive Multiple Sclerosis Patients

Clinical trial NCT03282760 · COMPLETED

Trial details

NCT number
NCT03282760
Sponsor
Casa Sollievo della Sofferenza IRCCS
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Secondary-progressive Multiple Sclerosis
Start date
2017-09-09
Primary completion
2021-05-29
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.